2012 Core Therapeutic Module, Women's Health

ACPE Number: 0204-0000-12-956-H01-P
Application-based: 1.0 Credit Hour
Release Date: 7/15/2012
Expiration Date: 7/15/2015

Let ASHP’s new online core therapeutic modules help you prepare for any Board of Pharmacy Specialties(BPS) examination. Get comprehensive, practical guidance for topics in women’s health, including contraception, osteoporosis, breast cancer, menopausal symptoms, prevention/screening, and health promotion, as well as practice exam questions and references to helpful study resources.  This activity is available July 15, 2012 through July 15, 2015.

Featured topics in this online CE activity include:

• Identifying how drug response differs based on gender.
• Identifying health screening for osteoporosis, breast cancer, endometrial cancer, cervical cancer.
• Determining the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines for osteoporosis, breast cancer and menopausal symptoms.
• Determining which contraceptive options are appropriate based on patient-specific information, including emergency contraception.
• Discussing complementary therapies for menopausal symptoms.

Led by therapeutic experts, each of the 14 modules (ranging from 1 to 2 hours in length) can be completed consecutively or individually in any order.  The online format offers the convenience of studying at your own pace. 

Included with this online course are complementary study resources including a practice exam and access to a virtual study group for a truly interactive experience.

 

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEUs) of continuing pharmacy education credit (ACPE activity #0204-0000-12-956-H01-P).

Methods and Format

This activity is one of 14 modules in this series and can be completed consecutively or individually in any order. This online activity consists of audio and slides for one presentation, an attestation statement, and activity evaluation. Participants must view the entire presentation, complete the attestation statement and course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 1 hour.

Target Audience

This activity is intended for pharmacy practitioners who are seeking to update their knowledge and skills commensurate with a board certification examination.

Activity Content

The purpose of this activity is to help participants prepare for a Board of Pharmacy Specialty (BPS) examination by providing a review of pertinent topics, practice of required skills and references to helpful study resources. Faculty will discuss therapeutic management of issues and provide resources on the disease state. The activity will assist the participant identify areas needed for in-depth review.

Learning Objectives

After participating in this application-based educational activity, participants should be able to

• Identify how drug response differs based on gender.
• Identify health screening for osteoporosis, breast cancer, endometrial cancer, cervical cancer.
• Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines for osteoporosis, breast cancer and menopausal symptoms.
• Determine which contraceptive options are appropriate based on patient-specific information, including emergency contraception.
• Discuss complementary therapies for menopausal symptoms.

Faculty

Christopher Brock Woodis, Pharm.D., BCACP, BCPS, CPP
Assistant Professor of Pharmacy Practice
Campbell University College of Pharmacy & Health Sciences
Buies Creek, North Carolina
Clinical Pharmacist
Duke Family Medicine
Durham, North Carolina

Dr. Brock Woodis is a native of Alabama where he attended the University of Alabama at Birmingham and received his Bachelor of Science degree in biology in 2001. He then continued his education at Auburn University, obtaining his Doctor of Pharmacy degree in 2005. Dr. Woodis completed both a postgraduate year one (PGY1) and PGY2 residency in family medicine and pharmacotherapy at the University of North Carolina Hospitals and Clinics in Chapel Hill. In 2006, Dr. Woodis became a board certified pharmacotherapy specialist, a clinical pharmacists practitioner in the state of North Carolina in 2010, and a board certified ambulatory care pharmacist in 2011.

Currently, Dr. Woodis is Assistant Professor of Pharmacy Practice with Campbell University College of Pharmacy & Health Sciences. In this role, he serves as both an ambulatory care preceptor for fourth-year pharmacy students on experimental rotations as well as having on-campus teaching responsibilities. In addition, he is Assistant Professor in the Department of Community and Family Medicine in the Duke University Medical Center and practices as a clinical pharmacy specialist at Duke Family Medicine (DFM). At DFM, he is involved in a variety of services including chronic disease state management, patient education, clinical consultation, resident teaching, and committee participation. His areas of interest include general family medicine as well as women’s health. Dr. Woodis is a member of North Carolina Association of Pharmacists, the American College of Clinical Pharmacy, and the American Society of Health-System Pharmacists.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.

The faculty and planners report the following relationships:

Christopher Brock Woodis, Pharm.D., BCACP, BCPS, CPP
Dr. Woodis declares that he has no relationships pertinent to this activity.

Christopher Betz, Pharm.D., BCPS
Dr. Betz declares that he has no relationships pertinent to this activity.

Sandra Oh Clarke, B.S.Pharm.
Ms. Oh Clarke declares that she has no relationships pertinent to this activity.

Susan R. Dombrowski, M.S., B.S.Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.

ASHP staff has no relevant financial relationships to disclose.